Case Name: Zogenix, Inc. v. Apotex Inc., Civ. No. 21-1252-RGA, 2023 WL 5835828 (D. Del. Sept. 8, 2023) (Andrews, J.) - Drug Product and Patent(s)-in-Suit: Fintepla® (fenfluramine HCl);.
Case Name: Horizon Medicines LLC v. Apotex Inc., Civ. No. 22-640-CJB, 2022 WL 16739909 (D. Del. Nov. 7, 2022) (Burke, M.J.) Drug Product and Patent(s)-in-Suit: Pennsaid® 2% (diclofenac.